Related Experiment Video
Updated: Jan 11, 2026

11:29
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
15.2K
P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery
Michail Sideris1,2, Mark R Brincat2, Oleg Blyuss1,3
1Wolfson Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK.
Cancers
|November 13, 2025
Summary
The P-POSSUM scale poorly predicts surgical morbidity in ovarian cancer patients undergoing cytoreductive surgery. Adding the Edmonton Frail Scale and BMI improved prediction, suggesting a need for enhanced models in gynecologic oncology.
Area of Science:
- Oncology
- Surgical Outcomes
- Predictive Analytics
Background:
- The P-POSSUM scale is a standard tool for predicting perioperative risk.
- Its efficacy in predicting outcomes after cytoreductive surgery (CRS) for ovarian cancer (OC) remains under-investigated.
- Accurate risk assessment is crucial for optimizing patient care in complex oncologic surgeries.
Purpose of the Study:
- To evaluate the predictive performance of the P-POSSUM scale for morbidity in patients undergoing CRS for OC.
- To explore the potential of incorporating additional clinical variables to enhance the predictive accuracy of existing models.
Main Methods:
- Retrospective analysis of 161 patients undergoing OC CRS.
- Data collected included demographics, P-POSSUM scores, Edmonton Frail Scale (EFS) scores, and preoperative albumin.
- Performance evaluated using ROC curves; stepwise regression identified additional predictors (EFS, BMI) for an improved model.
Main Results:
- P-POSSUM demonstrated poor predictive performance for morbidity (AUC=0.539) and mortality (AUC=0.569) in OC CRS.
- Forty percent of patients experienced postoperative complications (Clavien-Dindo grade ≥1).
- A combined model (P-POSSUM + EFS + BMI) showed improved, though not statistically significant, morbidity prediction (AUC=0.655).
Conclusions:
- The P-POSSUM scale is inadequate for predicting morbidity in OC CRS.
- Current models require enhancement with additional clinical factors like EFS and BMI.
- Further validation of refined predictive models is essential for clinical application in gynecologic oncology.

